A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma
Titel:
A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma
Auteur:
Enzler, T. Nguyen, A. Misleh, J. Cline, V.J. Johns, M. Shumway, N. Paulson, S. Siegel, R. Larson, T. Messersmith, W. Richards, D. Chaves, J. Pierce, E. Zalupski, M. Sahai, V. Orr, D. Ruste, S.A. Haun, A. Kawabe, T.